SCHEMBL23115986

SCHEMBL23115986

CCn1nc(CO)cc1-c1nncn1Cc1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ QPCTL Q9NXS2 3/20 0.47
▸ P2RX7 Q99572 2/20 0.42
▸ CYP11B1 P15538 3/20 0.39
▸ CYP11B2 P19099 3/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PDE1A P54750 1/20 0.38
▸ PDE1B Q01064 1/20 0.38
▸ PDE1C Q14123 1/20 0.38
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23115689 0.87 QPCTL (0.49) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL23115852 0.83 QPCTL (0.43) QPCTLP2RX7CYP11B1CYP11B2L3MBTL1
SCHEMBL23115688 0.78 QPCTL (0.45) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL23115720 0.75 QPCTL (0.46) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL23116078 0.75 QPCTL (0.46) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL26690111 0.74 QPCTL (0.45) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL17982169 0.73 CYP11B2 (0.52) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL22412857 0.73 MAPT (0.50) P2RX7CYP1A2CYP2C9MAPTKDM4E
SCHEMBL26690013 0.72 QPCTL (0.43) QPCTLP2RX7CYP11B1CYP11B2KMT2A
SCHEMBL23115918 0.72 QPCTL (0.41) QPCTLP2RX7CYP11B1CYP11B2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12297190-B2 Modulators of STING (stimulator of interferon genes) PFIZER INC. (US) 2025-05-13 — — US disclosed
EP-4034534-A1 POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) Pfizer Inc. (US) 2022-08-03 — — EP disclosed
WO-2021059136-A1 POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) PFIZER INC. (US) 2021-04-01 — — WO disclosed
WO-2021059136-A1 POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) PFIZER INC. (US) 2021-04-01 — — WO disclosed
US-20210087180-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2021-03-25 — — US disclosed
US-20210087180-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2021-03-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12297190-B2 Modulators of STING (stimulator of interferon genes) STING1, IRF3, CGAS QPCTL 2930/4885P2RX7 797/4885CYP11B1 974/4885
US-20210087180-A1 Modulators of STING (Stimulator of Interferon Genes) STING1, IRF3, CGAS QPCTL 2930/4885P2RX7 797/4885CYP11B1 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback